Proteins on the prowl

Researchers have identified the function of an obscure but large family of proteins whose function in cellular immune responses had been unknown.

Fluorescent micrograph of Gbp1 (green) targeting mycobacteria (magenta rods) in interferon-activated macrophages (red, actin staining;
blue, nuclear staining)
Image courtesy of John MacMicking

Guanylate-binding proteins, Gbps for short, protect cells from pathogens that have snuck into a cell by activating cellular degradation machinery, according to a study published today (May 5) in linkurl:Science.;http://www.sciencemag.org/content/current Understanding how the proteins work could help spur the development of small drug molecules to activate a cell's own defenses against infection, a potential alternative to antibiotics."The function of the Gbps remained mysterious for a very long time despite the fact that they are produced in massive amounts upon infection," said linkurl:Sascha Martens,;http://www.mfpl.ac.at/index.php?cid=872 who studies autophagy at the Max F. Perutz Laboratories in Austria and was not involved in the research, in an email to The Scientist. The new findings "could be a breakthrough in the field of resistance to intracellular bacterial pathogens."Gbps are produced in abundance in response to type II interferon, a defense activation protein released by host cells in presence of pathogens. linkurl:John MacMicking;http://medicine.yale.edu/micropath/people/john_macmicking.profile and colleagues at the Yale University School of Medicine performed a loss of function screen on the 11 members of the Gbp family, individually silencing the RNA transcripts of the genes in mouse macrophages. "Now that we can target RNA, it allows us to discriminate between individual members of a closely related family," said MacMicking.The researchers found that four of the Gbps -- Gbp1, Gbp6, Gbp7, and Gbp10 -- conferred immunity to two bacteria: Listeria monocytogenes, responsible for food borne infection in humans, and Mycobacerium bovis, a close relative to the bacterium that causes tuberculosis. Engineering Gbp1-deficient mice, the team confirmed that animals lacking the Gbp1 gene were more susceptible to infection.Digging into the mechanism by which the proteins protect the cells, the researchers found that at least two of them, Gbp1 and Gbp7, deliver antimicrobial cargo such as toxic peptides to the bacteria in sac-like vesicles (see below video). Gbp1 also tags invading bacterial cells so that they are delivered to lysosomes and digested.

Microbiologist John MacMicking shows how specialized proteins
battle bacteria inside immune cells.
Video courtesy of Science and John MacMicking

The team conducted additional experiments in human cells and found that human orthologs of the Gbp proteins also help fight infection. "It looks like there's conservation across both human and mouse, and we anticipate there will be conservation across other vertebrate species as well," said MacMicking.Understanding how the cell's internal defensive machinery works could help scientists develop small molecule drugs that imitate its ability to fight and kill bacteria. "We're running out of new antibiotics," said MacMicking. "One idea is to eventually generate drugs that actually mimic host processes that are normally very effective at clearing bacteria." Kim, B.H., et al., "A family of IFN-gamma inducible 65-kD GTPases protects against bacterial infection," Science, 332:717-21, 2011.
**__Related stories:__***linkurl:Cellular chaos fights infection;http://www.the-scientist.com/news/display/57982/
[10th February 2011] *linkurl:RNA Arms Race;http://www.the-scientist.com/2010/8/1/51/1/
[1st August 2010] *linkurl:Antiviral response promotes bacterial infection;http://www.the-scientist.com/news/display/25036/
[10th October 2006]

Proteins on the prowl

The Scientist ARCHIVES

Become a Member of

Meet the Author

Megan Scudellari

Related Research Resources

What Is the Amniotic Fluid Composed of?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform